Allianz Asset Management GmbH - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$681,000
-75.6%
14,814
-64.8%
0.00%
-50.0%
Q4 2021$2,794,000
+61.8%
42,092
+52.2%
0.00%
+100.0%
Q3 2021$1,727,000
-23.8%
27,660
+1.1%
0.00%
-50.0%
Q2 2021$2,265,000
+1.1%
27,351
-19.1%
0.00%0.0%
Q1 2021$2,241,000
-58.1%
33,803
-51.5%
0.00%
-60.0%
Q4 2020$5,352,000
+931.2%
69,735
+479.1%
0.01%
+400.0%
Q3 2020$519,000
+6.1%
12,043
+6.4%
0.00%0.0%
Q2 2020$489,000
+60.3%
11,315
+6.9%
0.00%
Q1 2020$305,000
-93.4%
10,584
-85.4%
0.00%
-100.0%
Q4 2019$4,609,000
+251.0%
72,659
+56.0%
0.00%
+300.0%
Q3 2019$1,313,000
-70.2%
46,589
-71.9%
0.00%
-75.0%
Q2 2019$4,401,000
+14.3%
166,089
-20.8%
0.00%0.0%
Q1 2019$3,849,000
+52.2%
209,745
+3.0%
0.00%
+33.3%
Q4 2018$2,529,000
+48.7%
203,613
-55.9%
0.00%
+200.0%
Q4 2017$1,701,000
-13.1%
462,105
+2.2%
0.00%
-50.0%
Q3 2017$1,958,000
+11.9%
452,120
+89.9%
0.00%0.0%
Q3 2016$1,750,000238,0820.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders